FDA Releases First-Ever Draft Guidance on Psychedelic Drug Research

FDA releases draft guidance for researchers studying psychedelic drugs in medicine, emphasizing the need for unique considerations in clinical trials

FDA’s groundbreaking guidance aims to advance psychedelic drug research and promote safety.

Psychiatrist.com